Home/Filings/4/0001062993-23-004892
4//SEC Filing

Montecalvo Antonio S. 4

Accession 0001062993-23-004892

CIK 0001661181other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 5:51 PM ET

Size

7.1 KB

Accession

0001062993-23-004892

Insider Transaction Report

Form 4
Period: 2023-02-22
Montecalvo Antonio S.
Vice President, Health Policy
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-22+118,035118,035 total
    Exercise: $2.51Exp: 2033-02-22Class A Common Stock (118,035 underlying)
  • Award

    Class A Common Stock

    2023-02-22+99,428139,013 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2023.
  • [F2]The option becomes exercisable in equal annual installments over four years beginning February 15, 2023.

Issuer

Organogenesis Holdings Inc.

CIK 0001661181

Entity typeother

Related Parties

1
  • filerCIK 0001759261

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:51 PM ET
Size
7.1 KB